Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study

Kenshi Yamasaki, Keiichi Yamanaka, Yiwei Zhao, Shunsuke Iwano, Keiko Takei, Koji Suzuki, Toshiyuki Yamamoto

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint Dive into the research topics of 'Adalimumab in Japanese patients with active ulcers of pyoderma gangrenosum: Twenty-six-week phase 3 open-label study'. Together they form a unique fingerprint.

Medicine & Life Sciences